It is known that metabolic diseases such as diabetes can result in increased blood–brain barrier permeability that potentially, further progresses to Alzheimer’s disease with the accumulation of amyloid beta peptides. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.